HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Girija Kuttan Selected Research

Uronic Acids

1/2010Inhibition of metastasis of B16F-10 melanoma cells in C57BL/6 mice by an extract of Calendula officinalis L flowers.
1/2008Anti-metastatic effect of Biophytum sensitivum is exerted through its cytokine and immunomodulatory activity and its regulatory effect on the activation and nuclear translocation of transcription factors in B16F-10 melanoma cells.
6/2007Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Girija Kuttan Research Topics

Disease

52Neoplasms (Cancer)
12/2016 - 12/2002
41Melanoma (Melanoma, Malignant)
12/2016 - 05/2006
21Neoplasm Metastasis (Metastasis)
08/2019 - 05/2006
19Body Weight (Weight, Body)
08/2019 - 12/2002
6Ascites
06/2012 - 01/2002
4Edema (Dropsy)
07/2015 - 01/2009
4Lymphoma (Lymphomas)
06/2012 - 01/2002
3Hypoxia (Hypoxemia)
01/2012 - 04/2009
3Inflammation (Inflammations)
06/2011 - 01/2009
2Necrosis
08/2011 - 03/2007
2Leukemia
09/2009 - 01/2008
2Sarcoma (Soft Tissue Sarcoma)
01/2007 - 06/2002
2Carcinoma (Carcinomatosis)
01/2007 - 01/2002
1Breast Neoplasms (Breast Cancer)
08/2019

Drug/Important Bio-Agent (IBA)

32CytokinesIBA
12/2016 - 01/2007
17Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016 - 01/2007
14Matrix Metalloproteinases (MMPs)IBA
12/2016 - 05/2006
12Transcription Factors (Transcription Factor)IBA
03/2012 - 06/2007
10Caspase 3 (Caspase-3)IBA
02/2012 - 01/2007
8Complement System Proteins (Complement)IBA
08/2016 - 01/2007
8Adenosine Monophosphate (AMP)IBA
02/2012 - 06/2007
8Interleukin-2 (IL2)IBA
10/2011 - 01/2007
7Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2016 - 01/2008
7Interleukin-6 (Interleukin 6)IBA
08/2016 - 03/2008
7EsterasesIBA
11/2015 - 08/2002
7Carrier Proteins (Binding Protein)IBA
02/2012 - 06/2007
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012 - 03/2007
7CollagenIBA
01/2012 - 05/2006
7Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2011 - 01/2007
7NF-kappa B (NF-kB)IBA
01/2011 - 06/2007
6InterleukinsIBA
02/2012 - 03/2008
5punarnavineIBA
08/2019 - 01/2007
5vernolide-AIBA
02/2012 - 01/2011
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2012 - 06/2007
5Messenger RNA (mRNA)IBA
01/2012 - 01/2007
5amentoflavoneIBA
01/2011 - 01/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2016 - 12/2002
4CarrageenanIBA
07/2015 - 01/2009
4polycarbonateIBA
01/2013 - 06/2011
4AlkaloidsIBA
02/2012 - 01/2007
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2011 - 03/2008
4Tissue Inhibitor of Metalloproteinase-1IBA
09/2011 - 01/2007
4Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
06/2011 - 01/2008
4gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2010 - 01/2007
3Pharmaceutical PreparationsIBA
12/2016 - 04/2011
3Formaldehyde (Formol)FDA Link
07/2015 - 02/2009
3Dextrans (Dextran)FDA Link
07/2015 - 02/2009
3DNA (Deoxyribonucleic Acid)IBA
06/2012 - 01/2007
3BerberineIBA
04/2012 - 01/2008
3Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
06/2011 - 01/2008
3EnzymesIBA
06/2011 - 01/2007
3Harmine (Telepathine)IBA
03/2011 - 12/2010
3Proteins (Proteins, Gene)FDA Link
01/2011 - 01/2011
3Uronic AcidsIBA
01/2010 - 06/2007
3Metalloproteases (Metalloproteinases)IBA
01/2010 - 01/2007
3Hydroxyproline (4 Hydroxyproline)IBA
01/2010 - 06/2007
3HexosaminesIBA
01/2010 - 06/2007
3Isotretinoin (Accutane)FDA LinkGeneric
01/2008 - 01/2007
2Pyruvic Acid (Pyruvate)IBA
03/2015 - 01/2007
2Glutathione (Reduced Glutathione)IBA
03/2015 - 01/2007
2Alkaline PhosphataseIBA
03/2015 - 01/2007
2Glutamic Acid (Glutamate)FDA Link
03/2015 - 01/2007
2Transaminases (Aminotransferases)IBA
03/2015 - 01/2007
2nomilinIBA
03/2012 - 10/2011
2Polysaccharides (Glycans)IBA
02/2012 - 10/2011
2andrographolideIBA
02/2012 - 01/2011
2Terpenes (Terpenoids)IBA
02/2012 - 10/2011
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2012 - 01/2011
2beta-thujone (thujone)IBA
12/2011 - 10/2011
2Tissue Inhibitor of Metalloproteinase-2IBA
10/2011 - 06/2011
2Tissue Inhibitor of MetalloproteinasesIBA
10/2011 - 06/2011
2LactonesIBA
09/2011 - 07/2011
2SesquiterpenesIBA
09/2011 - 07/2011
2Interferon-gamma (Interferon, gamma)IBA
09/2011 - 01/2007
2Cyclin D1IBA
07/2011 - 01/2011
2sulforaphaneIBA
07/2011 - 05/2006
2ipobscurineIBA
04/2011 - 01/2011
2TriterpenesIBA
01/2011 - 07/2008
2Ursolic AcidIBA
06/2010 - 07/2008
2Calendula extractIBA
01/2010 - 02/2009
2N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2010 - 01/2007
2Antiviral Agents (Antivirals)IBA
09/2009 - 01/2008
2BiflavonoidsIBA
01/2008 - 01/2007
2CurcuminIBA
01/2008 - 01/2007
22,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
12/2007 - 03/2007
2AbrinIBA
01/2006 - 01/2002
1Quinolizidine AlkaloidsIBA
08/2019
1humuleneIBA
12/2016
1curculigosideIBA
08/2016
1Alkylating AgentsIBA
01/2016
1Collagen Type I (Type I Collagen)IBA
01/2013
1FlavonoidsIBA
02/2012
1InterferonsIBA
02/2012
1AntigensIBA
01/2012
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2012

Therapy/Procedure

5Therapeutics
10/2011 - 12/2002
3Aftercare (After-Treatment)
01/2012 - 07/2007
3Oral Administration
09/2009 - 01/2008
2Drug Therapy (Chemotherapy)
07/2011 - 12/2002
1Intravenous Injections
04/2012